Geometry of human vascular system: Is it an obstacle for quantifying antiangiogenic therapies?

Applied Immunohistochemistry and Molecular Morphology

Volumn 15, Issue 2, 2007, Pages 134-139

  Grizzi, Fabio ^a,b   Colombo, Piergiuseppe ^a   Taverna, Gianluigi ^a   Chiriva Internati, Maurizio ^c   Cobos, Everardo ^c   Graziotti, Pierpaolo ^a   Muzzio, Pier Carlo ^d   Dioguardi, Nicola ^a,b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Michele Rodriguez Foundation   (Italy)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Angiogenesis; Complexity; Fractals; Microvessel density

Indexed keywords

ANGIOGENESIS INHIBITOR;

ANGIOGENESIS; CARDIOVASCULAR SYSTEM; FRACTAL ANALYSIS; GEOMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; THEORETICAL MODEL; TUMOR VASCULARIZATION;

FIBROBLAST GROWTH FACTOR 2; FRACTALS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34249665577     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000213105.18569.fa     Document Type: Review

References (34)

1. Nonnemacher TF, Losa GA, Merlini D, et al, eds. Fractals in Biology and Medicine. Vol. 1. Basel, Boston, Berlin: Birhkäuser Press; 1994.
2. Losa GA, Merlini D, Nonnemacher TF, et al, eds. Fractals in Biology and Medicne. Vol. 2. Basel, Boston, Berlin: Birhkäuser Press, 1998.
3. Losa G, Merlini D, Nonnemacher TF, et al. Fractals in Biology and Medicne. Vol. 3. Basel, Boston, Berlin: Birhkäuser Press; 2002.
4. Losa G, Merlini D, Nonnemacher TF, et al. Fractals in Biology and Medicne. Vol. 4. Basel, Boston, Berlin: Birhkäuser Press; 2005.
5. Baish JW, Jain RK. Fractals and cancer. Cancer Res. 2000;60:3683-3688.
6. Coffey DS. Self-organization, complexity and chaos: the new biology for medicine. Nat Med. 1998; 4:882-885.
7. Losa GA, Nonnenmacher TF. Self-similarity and fractal irregularity in pathologic tissues. Mod Pathol. 1996; 9:174-182.
8. Grizzi F, Ceva-Grimaldi G, Dioguardi N. Fractal geometry: a useful tool for quantifying irregular lesions in human liver biopsy specimens. Ital J Anat Embryol. 2001;106:337-346.
9. Cross SS. Fractals in pathology. J Pathol. 1988;182:1-8.
10. Luzi P, Bianciardi G, Miracco C, et al. Fractal analysis in human pathology. Ann NY Acad Sci. 1999;879:255-257.
11. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003;9:685-693.
12. Hogan BL, Kolodziej PA. Organogenesis: molecular mechanisms of tubulogenesis. Nat Rev Genet. 2002;3:513-523.
13. Lubarsky B, Krasnow MA. Tube morphogenesis: making and shaping biological tubes. Cell. 2003;112:19-28.
14. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9:653-660.
15. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 1999;284:1994-1998.
16. Grizzi F, Russo C, Colombo P, et al. Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension. BMC Cancer. 2005;5:14.
17. Sharma S, Sharma MC, Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology. 2005;46:481-489.
18. Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol. 1998;184:119-122.
19. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Nat Cancer Inst. 2002;94:883-893.
20. Grizzi F, Colombo P, Roncalli M, et al. Fractal quantification of neovascularity in human prostate adenocarcinoma [Abstract]. Lab Invest. 2000;80:581.
21. Hand DJ. Measurement: Theory and Practice. New York: Arnold; 2004.
22. Mandelbrot BB. The Fractal Geometry of the Nature. San Francisco: Freeman; 1983.
23. Grizzi F, Colombo P, Barbieri B, et al. Correspondence re: E. Sabo, et al, Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res. 2001;7:3305-3307.
24. Grizzi F, Chiriva-Internati M. The complexity of anatomical systems. Theor Biol Med Model. 2005;2:26.
25. Bassingthwaighte JB, Liebovitch LS, West BJ. Fractal Physiology. Oxford University Press: New York; 1994.
26. Hastings HM, Sugihara G. Fractals. A User's Guide for the Natural Sciences. Oxford: Oxford Science Publications; 1993.
27. Tandle A, Blazer III DG, Libutti SK. Antiangiogenic gene therapy of cancer: recent developments. J Transl Med. 2004;2:22.
28. Harris AL. Hypoxia - a key regulatory factor in tumor growth. Nat Rev Cancer. 2002;2:38-47.
29. Munn LL. Aberrant vascular architecture in tumors and its importance in drug-based therapies. Drug Discov Today. 2003;8:396-403.
30. Stergiopulos N, Porret CA, De Brouwer S, et al. Arterial vasomotion: effect of flow and evidence of nonlinear dynamics. Am J Physiol. 1998;274:H1858-H1864.
31. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307:58-62.
32. Webb T. Vascular normalization: study examines how antiangiogenesis therapies work. J Natl Cancer Inst. 2005;97:336-337.
33. Jain RK. Antiangiogenic therapy for cancer: current and emerging concepts. Oncology (Williston Park). 2005;19 (Suppl 3):7-16.
34. Margenau H. Philosophical problems concerning the meaning of measurement in physics. In: Churchman CW, Ratoosh P, eds. Measurement: Definitions and Theories. New York: Wiley; 1959:163-176.